Eris Lifesciences Limited vs Sun Pharmaceutical Industries Limited
A side-by-side comparison of Eris Lifesciences Limited (ERIS) and Sun Pharmaceutical Industries Limited (SUNPHARMA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
Eris Lifesciences Limited vs Sun Pharmaceutical Industries Limited are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.
- Valuation22
- Profitability31
- Growth20
- Size & financial health04
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
ERIS takes 3/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
ERIS takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
SUNPHARMA takes 4/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has delivered good sales growth of 20.9% CAGR over last 5 years"]
- − []
- + ["Company has delivered good profit growth of 38.3% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 33.4%", "Company is almost debt free."]
- − ["Stock is trading at 5.05 times its book value"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.